What a bloodbath today in the stock market. Some people have been asking the question:
So now what is Elon Musk going to do? The answer is that he may shift his base to Louisiana. Texas has changed, and although they have a lot of land, things may be better on the other side of the Mississippi.
––– 良くない–––
Sequoia Capital says
R.I.P. Good Times. Looking at their graphs, it seems the economy never really became healthy after Great Recession. And now, more bad times ahead.
––– 良くない–––
Keep looking, scientists.
––– 凄い –––
The cybersecurity vendor on Tuesday launched an AI kill switch designed to let security teams stop internal AI agents that go rogue, block them from relaunching and cut off their enterprise network access. The tool is built into CrowdStrike’s Falcon Guardian platform, launched in September to secure AI agents. CrowdStrike also announced an integration with Anthropic’s Claude Cowork.
We could just pull the plug.
––– 良くない–––
Something else to worry about now.
Hiding a Rule Inside Another Model's Weights. More on
weight-space programming. If you can hide a rule inside an open-weight model that everyone uses, think of all the havoc you could wreak. Because these small changes are undetectable unless you enter the right prompt. And people make copies and versions of these open-weight models all the time. Now, I imagine people will be more wary about provenance.
––– 良くない–––
Crazy.
Why isn’t Retatrutide Approved Yet? Eli Lilly hasn’t even filed an application. Why??? It all comes down to one amino acid short of a threshold. And so this drug is going to sit on the sidelines for a while.
––– 良くない–––
The experimental treatment uses a virus called adeno-associated virus 9 to deliver a gene to neurons in the affected area. The gene was engineered to produce proteins specifically in excitatory cells — the ones that are involved in seizures.
The viruses carried a gene that makes neurons sensitive to a specific drug, which works like a dimmer switch for the therapy. By combining gene therapy with a drug — an approach known as chemogenetics — researchers can adjust a treatment’s potency, which is not possible with other types of gene therapy.
The gene instructs neurons to produce a receptor that binds to clozapine, the anticonvulsant.
This was a Chinese research effort, so don't expect it to be available here soon.
––– 凄い –––
When Doctors and AI Medical Opinions Diverge, Humans Must Question the Difference. Well yes, but what do you when a patient, armed with his/her own AI model disagrees with you. Are you going to diss that person's LLM? Are you going to become an AI lecturer and review the principles of prompt structure, dataset selection and pretraining differences? Or tell them that the free tier on ChatGPT is inferior to the Claude Opus that you use, if you use it? One problem is that there are no good, widely accepted benchmarks.
––– 良くない–––